DECK: Non-Endocrine Targeted Treatments for HR+, HER2- MBC
This slide deck provides an overview of non-endocrine, targeted treatment options in HR+, HER2- MBC, including information on the MOA of different therapy classes and the phase 2/3 clinical studies for approved therapies in this setting.
Date of Last Review: April 17, 2024
Are you satisfied with this content?